Efficacy of Low Adjunctive Quetiapine Administration in Control of Hypomanic State in Bipolar Affective Disorder Captured by EEG
Journal Title: Journal of Neuroimaging in Psychiatry and Neurology - Year 2017, Vol 2, Issue 2
Abstract
Aim: According to current biopsychiatric models, hypomania is associated with subvigil patterns in EEG, suggesting a significant impact of instable vigilance dynamics to bipolar disorders. Quetiapine as a well-accepted treatment option in bipolar disorders has been suggested to modify vigilance regulation by its high affinity to 5HT1A receptors at raphe nucleus, so even a low dose administration of quetiapine might be quite efficient to guide the recovery of the presumed instable vigilance dynamic in hypomanic state of bipolar disorder. Methods: We report a patient with a bipolar disorder, who experienced a hypomanic state under an established drug treatment with valproic acid and olanzapine. For evaluation of therapeutic response to low dose quetiapine, structured clinical interview and discrete EEG analysis of initial and follow up recordings were administered. Results: Administration of a low dose of 50 mg quetiapine per night as an adjunctive treatment to prescribed psychopharmacologic drug formulation was followed not only by the intended improvement of sleep comfort, but also by a complete control of hypomanic state. Clinical improvement was accompanied with a restoring of initially EEG recorded patterns of impaired vigilance regulation. Conclusion: Our report emphasizes the advantage of stratifying presumed effectiveness of quetiapine already at low dose administration in controlling exacerbated bipolar disorders by combined clinical and neurophysiological approaches as suggested by EEG, in particular due to specific stabilizing mechanisms at the cerebral vigilance regulation system.
Authors and Affiliations
Michael Adamaszek, Sebastian Olbrich
Keywords
Related Articles
- EP ID EP309290
- DOI 10.17756/jnpn.2017-016
- Views 82
- Downloads 0
Cognitive Behaviour Therapy for Psychosis: Insights from Neuroimaging
Up to 40% of schizophrenia patients continue to suffer from distressing symptoms despite remaining compliant with their prescribed antipsychotic medication. Additional symptom reduction following cognitive behaviour ther...
Assessing the Effects of Software Platforms on Volumetric Segmentation of Glioblastoma
Background: Radiological assessments of biologically relevant regions in glioblastoma have been associated with genotypic characteristics, implying a potential role in personalized medicine. Here, we assess the reproduci...
Cocaine-Induced Posterior Reversible Encephalopathy Syndrome (PRES): A Case Report and Review of the Literature
Background: Posterior Reversible Encephalopathy Syndrome (PRES) is a clinical-radiological phenomenon that occurs due to a disruption in the autoregulation of the cerebral blood flow resulting i...
18F-AV133 Cerebral VMAT2 Binding Correlated with α-synuclein Spliced Variants in Parkinson’s Disease
The study was designed to evaluate the connections between genotyping and functional image-based phenotyping in Parkinson’s disease (PD). The associations between18F-AV133 cerebral vesicular monoamine transporter 2 (VMAT...
White Matter Hyperintensities in Older Adults and Motoric Cognitive Risk Syndrome
Introduction: Motoric cognitive risk (MCR) syndrome is a recently described pre-dementia syndrome characterized by slow gait and cognitive complaints that has been implicated as a predictor of cognitive decline and demen...